The application of liposomes connected with anti-PRDX2 antibodies in glioma represents a new therapeutic strategy. Research has shown that PRDX2 is an antioxidant enzyme that can serve as a therapeutic target and plays a crucial role in cancer progression. By using antibodies targeting PRDX2, the liposomes can more effectively target and kill glioma cells, thereby improving the selectivity and efficiency of the treatment.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-1011MZ | Chicken Anti-PRDX2 Polyclonal IgY | WB | Chicken antibody |
There are currently no Customer reviews or questions for VS-1024-FY124. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.